- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 836880
Total 1215 results
-
Massachusetts General HospitalBoston UniversityCompletedType 1 DiabetesUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, Greece, India, Philippines, Thailand, Ukraine
-
LiuYingNot yet recruitingColorectal Cancer | Neoadjuvant Therapy | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)China
-
Boston University Charles River CampusMassachusetts General Hospital; National Institute of Diabetes and Digestive... and other collaboratorsCompletedIntegration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas (CL2)Diabetes MellitusUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, Germany, India, Ireland, Japan, Switzerland
-
Asahi Kasei Pharma CorporationRecruitingType 2 Diabetes MellitusChina
-
SIGA TechnologiesUnited States Department of DefenseCompleted
-
Gradalis, Inc.Completed
-
SangathCompletedHazardous DrinkingIndia
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimRecruitingNetherton SyndromeBelgium, United Kingdom, Australia, Germany, China, Malaysia, United States, Japan, France, Israel, Bulgaria, Italy, Switzerland, Netherlands, Portugal
-
Boehringer IngelheimCompletedAlzheimer DiseaseUnited States, Canada, United Kingdom, Germany, Portugal, France, Belgium, Netherlands, Austria, Poland, Italy
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, China, Germany, Taiwan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
CephalonCompletedAnxiety DisordersUnited States, Canada
-
Boehringer IngelheimCompleted
-
AbbVieBoehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
BioInvent International ABMerck Sharp & Dohme LLCRecruitingAdvanced MalignanciesUnited Kingdom, Denmark, Hungary, Russian Federation
-
Peking Union Medical College HospitalCompleted
-
Boehringer IngelheimCompletedDiabetic NephropathiesSpain, Germany, United Kingdom, France, Greece, Portugal, Sweden, Russian Federation, Denmark, Slovakia
-
Gradalis, Inc.Active, not recruitingOvarian Neoplasms | Ovarian CancerUnited States
-
Boehringer IngelheimCompleted
-
AbbVieBoehringer IngelheimCompleted
-
InxMed (Shanghai) Co., Ltd.Not yet recruiting
-
Boehringer IngelheimRecruiting
-
InxMed (Shanghai) Co., Ltd.Recruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Canada, Colombia, Czech Republic, Finland, Hong Kong, India, Italy, Malaysia, Mexico, Netherlands, Norway, Philippines, Portugal, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United...
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Fudan UniversityRecruitingAdvanced Salivary Gland CarcinomaChina
-
Hadassah Medical OrganizationCompletedResorbed Alveolar Ridge Prior to Dental Implant InsertionIsrael
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
AbbVieActive, not recruitingCrohn's DiseaseUnited States, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Egypt, Estonia, France, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Japan, Korea, Republic... and more
-
Boehringer IngelheimTerminated
-
Ohio State UniversityCompletedHepatitis C | HCV | Kidney TransplantUnited States
-
BioInvent International ABTerminatedA Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple MyelomaMultiple MyelomaUnited States
-
Cairo UniversityRecruitingSystemic Lupus ErythematosusEgypt